VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $1,936,000 | +8.5% | 13,531 | -0.5% | 0.03% | +3.0% |
| Q3 2014 | $1,784,000 | -24.3% | 13,597 | -27.2% | 0.03% | -21.4% |
| Q2 2014 | $2,358,000 | +2.0% | 18,689 | +6.5% | 0.04% | -4.5% |
| Q1 2014 | $2,312,000 | +29.9% | 17,541 | +15.6% | 0.04% | +51.7% |
| Q4 2013 | $1,780,000 | +2.6% | 15,168 | -8.9% | 0.03% | -12.1% |
| Q3 2013 | $1,735,000 | +24.0% | 16,643 | +2.1% | 0.03% | +10.0% |
| Q2 2013 | $1,399,000 | – | 16,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |